Related Experiment Video
Updated: Jan 22, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Ventilator associated pneumonia due to carbapenem resistant microorganisms in children
Soner S Kara1, Meltem Polat2, Anil Tapisiz2
1Unit of Pediatric Infectious Diseases, Medical Faculty, Gazi University, Ankara, Turkey - drsoner@yahoo.com.
Background:
Infections due to carbapenem resistant pathogens have become a major health threat especially for hospitalized patients. Acinetobacter baumanii (AB) and Pseudomonas aeruginosa (PA) are important pathogens causing ventilator-associated pneumonia (VAP) with a trend of high resistance to carbapenems. The aim of this study is to investigate the risk factors for VAP due to carbapenem resistant Acinetobacter baumanii (CRAB) and Pseudomonas aeruginosa (CRPA) in children.
Methods:
Between 2009 and 2013, an active, prospective observational study was conducted in Gazi University Hospital. Patients from Pediatric Intensive Care Unit (PICU), between 1 month and 12 years of age with VAP due to AB and PA were included.
Results:
During this period, 74 children experienced 126 VAP episodes due to Acinetobacter baumanii (N.=58) and Pseudomonas aeruginosa (N.=68). Among these, 93.1% (N.=54) of AB and 51.5% (N.=35) of PA were carbapenem resistant. In univariate analysis, length of stay in PICU until the diagnosis of VAP, presence of central venous catheters, prior use of cefepime, ciprofloxacin, colistin, and teicoplanin were associated with VAP due to CRPA (P=0.02, P=0.02, P=0.006, P=0.01, P=0.001, and P=0.009 respectively). Significant association was not found between the development of VAP due to CRAB and the investigated risk factors. Regression analyses revealed previous use of cefepime (OR, 2.11; 95% CI, 0.016-0.595, P=0.039) and colistin (OR: 2.33; 95% CI: 0.061-0.789, P=0.023) to be independently associated with VAP due to CRPA.
Conclusions:
This study suggests that broad spectrum antibiotic usage was the most important risk factor for the development of VAP due to CRPA.
Insights
Broad-spectrum antibiotic use increases the risk of ventilator-associated pneumonia (VAP) in children caused by carbapenem-resistant Pseudomonas aeruginosa (CRPA). Prior use of cefepime and colistin were independently associated with CRPA VAP.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Antimicrobial resistance
Background:
- Carbapenem-resistant pathogens pose a significant threat, particularly in hospitalized patients.
- Acinetobacter baumanii (AB) and Pseudomonas aeruginosa (PA) are key causes of ventilator-associated pneumonia (VAP), often exhibiting high carbapenem resistance.
- Ventilator-associated pneumonia (VAP) in children due to carbapenem-resistant Acinetobacter baumanii (CRAB) and carbapenem-resistant Pseudomonas aeruginosa (CRPA) requires investigation into associated risk factors.
Purpose of the Study:
- To identify risk factors for VAP caused by CRAB and CRPA in pediatric patients.
- To analyze the association between previous antibiotic use and the development of CRPA and CRAB VAP.
- To inform clinical practice and infection control strategies for pediatric VAP.
Main Methods:
- A prospective observational study was conducted from 2009 to 2013 at Gazi University Hospital.
- Included were pediatric patients (1 month to 12 years) in the Pediatric Intensive Care Unit (PICU) diagnosed with VAP due to AB and PA.
- Univariate and regression analyses were used to identify risk factors associated with CRPA and CRAB VAP.
Main Results:
- Of 126 VAP episodes, 58 were due to AB (93.1% carbapenem-resistant) and 68 to PA (51.5% carbapenem-resistant).
- Univariate analysis linked CRPA VAP to longer PICU stays, central venous catheters, and prior use of cefepime, ciprofloxacin, colistin, and teicoplanin.
- Previous cefepime and colistin use were independently associated with CRPA VAP (OR 2.11 and 2.33, respectively). No significant risk factors were found for CRAB VAP.
Conclusions:
- Broad-spectrum antibiotic usage is a primary risk factor for VAP caused by CRPA in children.
- Targeted antibiotic stewardship and infection control measures are crucial for preventing CRPA VAP.
- Further research is needed to elucidate risk factors for CRAB VAP in pediatric populations.
Related Concept Videos
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Types of Microorganisms
Mutations in Microorganisms
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology

